KittyHawk Ventures
KittyHawk Ventures is a venture capital firm based in Santa Monica, California, founded in 2015. The firm focuses on investing in innovative companies ranging from seed to late-stage pre-IPO. KittyHawk Ventures aims to support mission-driven entrepreneurs who are working to create transformative organizations across various sectors. The firm employs two primary investment strategies: KittyHawk Frontier, which targets seed-stage investments in cutting-edge technologies such as artificial intelligence, quantum computing, aerospace, healthcare, longevity, climate, and Web 3; and KittyHawk Secondaries, which concentrates on pre-IPO secondary investments by leveraging strong relationships with Nasdaq Private Markets to identify opportunities in leading late-stage companies.
InflammaSense
Funding Round in 2023
InflammaSense, now known as VitalX, is a health technology company dedicated to early detection of sepsis and other inflammatory diseases through innovative monitoring devices. These devices are designed to record continuous biological signals, including ECG, respiratory rate, and oxygen saturation, along with a patent-pending neural signal that specifically targets the vagus nerve. By providing real-time data, VitalX enables healthcare professionals to identify early signs of sepsis and respond promptly, potentially saving lives. The company's approach emphasizes the importance of immediate communication, as it transmits early sepsis alarms directly to clinicians, facilitating timely and informed decision-making in critical care settings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.